India vaccinates 190,000 on first day of campaign
Print Edition
India’s COVID-19 vaccination drive had a successful start on Saturday with more than 190,000 people receiving their first jabs and no one hospitalized for major side effects.
Authorities have given emergency-use approval for two vaccines — Oxford/AstraZeneca and the homegrown Covaxin, which has yet to complete its Phase-3 trials — and plans to immunize some 300 million people in the country of 1.3 billion by July.
Front-line workers such as hospital staff, people over 50 and those deemed to be at high risk due to pre-existing medical conditions are on the shortlist.
“We have got encouraging and satisfactory feedback results on the first day,” Health Minister Harsh Vardhan said on Saturday.
“This vaccine will indeed be a ‘Sanjeevani’ (life saver)” in the fight against the coronavirus, he added.
The health ministry said “no case of post-vaccination hospitalization” had been reported, although local media said a security guard at the country’s top-ranked public hospital had developed an allergic reaction shortly after getting his vaccine shot.
A doctors’ representative body at the Ram Manohar Lohia Hospital in New Delhi wrote a letter asking for the Oxford/AstraZeneca “Covishield” vaccine to be supplied instead of Covaxin to allay any fears.
“The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination,” said the letter addressing the hospital’s medical superintendent.
“We request you to vaccinate us with Covishield, which has completed all stages of trial before its rollout.”
Pathologist Arvind Ahuja said at the hospital on Saturday that he shared some of the concerns.
“I hope when the data comes out, it is good. Ideally, they should have waited for one month at least as then we would have known better about its efficacy.”
Vaccine hesitancy has emerged as a major concern, with a recent survey of 18,000 people across India finding that 69 percent were in no rush to get a shot.
Leading scientists and doctors have called on authorities to release efficacy data about Covaxin to boost confidence about the vaccine.
Covaxin recipients on Saturday had to sign a consent form that stated its “clinical efficacy ... is yet to be established.”
Officials had hoped to inoculate 300,000 people on Saturday but said glitches with an app used to coordinate and monitor the process meant not all potential recipients were alerted.
The drive also hit a bump on the first day due to glitches in an app called Co-Win that is being used to coordinate the campaign.
Co-Win, developed by the government, is supposed to help by alerting health-care workers who are first in line to get shots, and by allowing officials monitor and manage the entire drive.
But a lot of health workers who were to receive the vaccines did not get the message on Saturday, said a senior official with the health department of the western state of Maharashtra.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
